MyFinsight
Home
Blog
About
PMV Pharmaceuticals, Inc. (PMVP)
PMV Pharmaceuticals, Inc. (PMVP)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
770.33%
Quick Ratio
770.33%
Cash Ratio
117.99%
Debt to Asset Ratio
12.88%
Unit: Thousand (K) dollars
Assets Breakdown
Marketable securities, current
Cash and cash equivalents
Prepaid expenses and other curre...
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Accounts payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Cash and cash equivalents
12,469
39,130
36,337
44,127
Marketable securities, current
66,962
54,419
92,913
98,147
Prepaid expenses and other current assets
1,978
2,231
3,199
3,037
Total current assets
81,409
95,780
132,449
145,311
Property and equipment, net
154
203
255
287
Right-of-use assets
209
283
891
977
Marketable securities, noncurrent
-
-
-
6,032
Other assets
296
296
249
248
Total assets
82,068
96,562
133,844
152,855
Accounts payable
2,020
1,631
3,399
2,598
Accrued expenses
8,331
6,671
8,515
8,632
Operating lease liabilities, current
217
293
390
377
Total current liabilities
10,568
8,595
12,304
11,607
Operating lease liabilities, noncurrent
0
0
541
643
Total liabilities
10,568
8,595
12,845
12,250
Additional paid-in capital
554,160
552,474
549,325
547,942
Accumulated deficit
-482,578
-464,492
-428,417
-407,358
Accumulated other comprehensive income (loss)
-82
-15
91
21
Total stockholders equity
71,500
87,967
120,999
140,605
Total liabilities and stockholders equity
82,068
96,562
133,844
152,855
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Marketable securities,
current
$66,962K
(-31.77%↓ Y/Y)
Cash and cash
equivalents
$12,469K
(-71.74%↓ Y/Y)
Prepaid expenses and
other current assets
$1,978K
(-34.87%↓ Y/Y)
Total current assets
$81,409K
(-43.98%↓ Y/Y)
Other assets
$296K
(19.35%↑ Y/Y)
Right-of-use assets
$209K
(-78.61%↓ Y/Y)
Property and equipment,
net
$154K
(-46.34%↓ Y/Y)
Total assets
$82,068K
(-46.31%↓ Y/Y)
Total liabilities and
stockholders equity
$82,068K
(-46.31%↓ Y/Y)
Total stockholders
equity
$71,500K
(-49.15%↓ Y/Y)
Total liabilities
$10,568K
(-13.73%↓ Y/Y)
Accumulated deficit
-$482,578K
(-18.47%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$82K
(-490.48%↓ Y/Y)
Additional paid-in capital
$554,160K
(1.13%↑ Y/Y)
Total current
liabilities
$10,568K
(-8.95%↓ Y/Y)
Accrued expenses
$8,331K
(-3.49%↓ Y/Y)
Accounts payable
$2,020K
(-22.25%↓ Y/Y)
Operating lease
liabilities, current
$217K
(-42.44%↓ Y/Y)
Buy us a coffee